Schroder Ventures Life Sciences

Schroder Ventures Life Sciences is a prominent venture capital firm specializing in the life sciences sector, focusing on investments in biotechnology, pharmaceuticals, medical devices, and healthcare services. With a team of dedicated professionals in London and Boston, the firm has established itself as a leading international life sciences investor, advising funds of approximately $600 million and having invested in more than 100 life sciences companies worldwide.

The firm's investment strategy encompasses a broad spectrum of stages, including seed, early stage, Series A, Series B, growth, late stage, pre-IPO, buyout, turnaround, and distressed investments. Geographically, Schroder Ventures Life Sciences has a diverse focus, investing in countries such as the United Kingdom, United States, Germany, France, Italy, Spain, Netherlands, Sweden, Switzerland, Belgium, Denmark, Norway, Finland, Ireland, Austria, Poland, Portugal, Greece, Czech Republic, and Hungary. The firm targets a wide range of industries within the life sciences sector, including biotechnology, pharmaceuticals, medical devices, healthcare services, diagnostics, and various other sub-sectors.

Schroder Ventures Life Sciences has a consistent track record of delivering top quartile performance across its portfolios, with significant outperformance over benchmark indices. Through close partnerships with premier venture managers globally, the firm has been early investors in over 100 'unicorns' with an exit value in excess of $1 billion. This success is attributed to their global coverage of major innovation hubs, enabling them to capture opportunities wherever they arise, and their consistent value creation across diverse life sciences sectors.